Definitive Contract 75A50119C00030
Award Date
4/15/19
Potential Completion Date
10/14/20
Potential Value
$711K
Awardee
Janus-I Science Inc.
Ultimate Awardee
Not listed
NAICS Category
541715 - Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Vista, CA 92081, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
<p>This is a $747,499.00 firm fixed price definitive contract awarded by the Office of the Assistant Secretary for Preparedness and Response, a civilian federal agency, to Bugseq Inc., a for-profit foreign-owned company, to provide development and clinical validation from metagenomics data using AI and machine learning techniques. The contract has an ultimate completion date of July 23, 2025 and was awarded on June 21, 2024. The contract does not have a set-aside designation.</p>
The U.S. Department of Health and Human Services (HHS) Office of the Assistant Secretary for Preparedness and Response awarded a $4,283,030.88 firm fixed price purchase order to Bioinfoexperts LLC, a woman-owned small business. The contract is for genomic sequencing of SARS-CoV-2 variants and will run for three years, with a completion date of September 26, 2026. As a small business specializing in pathogen genomics, bioinformatics, and software solutions, Bioinfoexperts will leverage its...
The U.S. Department of Health and Human Services (HHS), Office of the Assistant Secretary for Preparedness and Response, awarded a $740,000.00 definitive, firm-fixed-price contract to Jumpcode Genomics Inc. for CRISPR-powered next-generation sequencing (NGS)-based agnostic diagnostic capabilities under the Division of Research, Innovation, and Ventures (DRIVe) Easy Broad Agency Announcement (EZ-BAA). This contract, which has a period of performance through September 25, 2023, was awarded on a...
This is a $14,400.00 firm fixed price purchase order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency, to Personal Diagnostix Inc., a minority-owned and small disadvantaged business, for Ion Torrent sequencing of RNA virus samples. The contract has an ultimate completion date of April 25, 2013 and does not have a set-aside designation. This contract appears to be for NIAID's research and development activities related to viral diagnostics...
This is a $113,182,532.15 definitive contract awarded to Cepheid Inc., a for-profit manufacturer of molecular diagnostic solutions, by the Office of the Assistant Secretary for Preparedness and Response (ASPR) for pandemic preparedness and response. The contract is to establish a platform for diagnosis and surveillance of emerging threats and is not designated with a set-aside. The original solicitation was a Broad Agency Announcement from the Biomedical Advanced Research and Development...
This is a firm fixed-price purchase order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the U.S. Department of Health and Human Services, to Macrogen Clinical Laboratory, Inc. (doing business as Macrogen USA) for transcriptome sequencing services of up to 4GB in size. The contract has a ceiling value of $4,710.00 and an ultimate completion date of September 30, 2015. The contract was awarded on May 15, 2015 and does not have a set-aside...
This is a firm fixed price delivery order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the U.S. Department of Health and Human Services, to Illumina, Inc. The $24,800 contract is for the provision of various Illumina sequencing systems, reagents, and related services to support genomic sequencing and analysis. No set-aside designations are noted. Illumina has previously received prime contracts and subcontracts from other federal...
This is a federal contract awarded by the Department of Health and Human Services (HHS) to Illumina, Inc., a manufacturer and provider of sequencing and array-based solutions for genetic and genomic analysis. The contract has an award value of $229,032 and is a firm fixed-price purchase order with an ultimate completion date of April 10, 2019. The contract does not have a set-aside designation. The award provides for Illumina to deliver various sequencing systems, reagents, consumables, and...
This is a federal contract awarded by the Office of the Assistant Secretary for Preparedness and Response (ASPR), a civilian agency, to Pattern Bioscience, Inc., a biotechnology company, to develop a rapid pathogen identification and antimicrobial susceptibility testing platform. The contract, valued at $40,937,536.73, is for the verification, clinical evaluation, and U.S. Food and Drug Administration (FDA) clearance of this culture-free, phenotypic diagnostic platform. The contract is a...
This is a $38,900,000.00 firm fixed-price definitive contract awarded by the Office of the Assistant Secretary for Preparedness and Response (ASPR) to Hologic, Inc. to ensure test availability for SARS-CoV-2 after the emergency authorization closes. The purpose is for Hologic to submit an in vitro diagnostic (IVD) assay for SARS-CoV-2, influenza A, influenza B, and respiratory syncytial virus (RSV) by September 30, 2027. This contract was awarded under a Broad Agency Announcement (BAA)...